The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial
Abstract The aim of the Complementary Nursing in Gynecologic Oncology study was to investigate the effects of a complex, nurse‐led, supportive care intervention using Complementary and Integrative Medicine (CIM) on patients’ quality of life (QoL) and associated patient‐reported outcomes. In this pro...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-07-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.2196 |
| _version_ | 1811224730402816000 |
|---|---|
| author | Nadja Klafke Cornelia Mahler Cornelia vonHagens Lorenz Uhlmann Martina Bentner Andreas Schneeweiss Andreas Mueller Joachim Szecsenyi Stefanie Joos |
| author_facet | Nadja Klafke Cornelia Mahler Cornelia vonHagens Lorenz Uhlmann Martina Bentner Andreas Schneeweiss Andreas Mueller Joachim Szecsenyi Stefanie Joos |
| author_sort | Nadja Klafke |
| collection | DOAJ |
| description | Abstract The aim of the Complementary Nursing in Gynecologic Oncology study was to investigate the effects of a complex, nurse‐led, supportive care intervention using Complementary and Integrative Medicine (CIM) on patients’ quality of life (QoL) and associated patient‐reported outcomes. In this prospective, pragmatic, bicentric, randomized controlled trial, women with breast or gynecologic cancer undergoing a new regimen of chemotherapy (CHT) were randomly assigned to routine supportive care plus intervention (intervention group, IG) or routine care alone (control group, CG). The intervention consisted of CIM applications and counseling for symptom management, as well as CIM information material. The primary endpoint was global QoL measured with the EORTC‐QLQ‐C30 before and after CHT. Mixed linear models considering fixed and random factors were used to analyze the data. In total, 126 patients were randomly assigned into the IG and 125 patients into the CG (median age 51 years). The patients’ medical and socio‐demographic characteristics were homogenous at baseline and at follow‐up. No group effects on QoL were found upon completion of CHT (estimate −1.04 [−4.89; 2.81]; P = 0.596), but there was a significant group difference in favor of the IG 6 months later (estimate 6.643 [1.65; 11.64]; P = 0.010). IG patients did also experience significant better emotional functioning (P = 0.007) and less fatigue (P = 0.027). The tested supportive intervention did not improve patients’ QoL outcomes directly after CHT (T3), but was associated with significant QoL improvements when considering the change from baseline to the time point T4, which could be assessed 6 months after patients’ completion of CHT. This delayed effect may have resulted due to a strengthening of patients’ self‐management competencies. |
| first_indexed | 2024-04-12T08:53:30Z |
| format | Article |
| id | doaj.art-2779d338c04840d083e261e6073fd794 |
| institution | Directory Open Access Journal |
| issn | 2045-7634 |
| language | English |
| last_indexed | 2024-04-12T08:53:30Z |
| publishDate | 2019-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj.art-2779d338c04840d083e261e6073fd7942022-12-22T03:39:28ZengWileyCancer Medicine2045-76342019-07-01883666367610.1002/cam4.2196The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trialNadja Klafke0Cornelia Mahler1Cornelia vonHagens2Lorenz Uhlmann3Martina Bentner4Andreas Schneeweiss5Andreas Mueller6Joachim Szecsenyi7Stefanie Joos8Department of General Practice and Health Services Research University Hospital Heidelberg Heidelberg GermanyDepartment of Nursing Institute for Health Sciences University Hospital Tuebingen Tuebingen GermanyDivision of Naturopathy and Integrative Medicine Department of Gynaecological Endocrinology and Reproductive Medicine University Womens’ Hospital Heidelberg Heidelberg GermanyInstitute of Medical Biometry and Informatics University of Heidelberg Heidelberg GermanyDepartment of General Practice and Health Services Research University Hospital Heidelberg Heidelberg GermanyDivision Gynaecologic Oncology National Center for Tumor Diseases University Hospital Heidelberg Heidelberg GermanyWomens’ Clinic Community Hospital Karlsruhe Karlsruhe GermanyDepartment of General Practice and Health Services Research University Hospital Heidelberg Heidelberg GermanyInstitute of General Practice and Interprofessional Care University Hospital Tuebingen Tuebingen GermanyAbstract The aim of the Complementary Nursing in Gynecologic Oncology study was to investigate the effects of a complex, nurse‐led, supportive care intervention using Complementary and Integrative Medicine (CIM) on patients’ quality of life (QoL) and associated patient‐reported outcomes. In this prospective, pragmatic, bicentric, randomized controlled trial, women with breast or gynecologic cancer undergoing a new regimen of chemotherapy (CHT) were randomly assigned to routine supportive care plus intervention (intervention group, IG) or routine care alone (control group, CG). The intervention consisted of CIM applications and counseling for symptom management, as well as CIM information material. The primary endpoint was global QoL measured with the EORTC‐QLQ‐C30 before and after CHT. Mixed linear models considering fixed and random factors were used to analyze the data. In total, 126 patients were randomly assigned into the IG and 125 patients into the CG (median age 51 years). The patients’ medical and socio‐demographic characteristics were homogenous at baseline and at follow‐up. No group effects on QoL were found upon completion of CHT (estimate −1.04 [−4.89; 2.81]; P = 0.596), but there was a significant group difference in favor of the IG 6 months later (estimate 6.643 [1.65; 11.64]; P = 0.010). IG patients did also experience significant better emotional functioning (P = 0.007) and less fatigue (P = 0.027). The tested supportive intervention did not improve patients’ QoL outcomes directly after CHT (T3), but was associated with significant QoL improvements when considering the change from baseline to the time point T4, which could be assessed 6 months after patients’ completion of CHT. This delayed effect may have resulted due to a strengthening of patients’ self‐management competencies.https://doi.org/10.1002/cam4.2196breast cancerchemotherapycomplementary therapiesgynecologic cancerhealth services researchnursing intervention |
| spellingShingle | Nadja Klafke Cornelia Mahler Cornelia vonHagens Lorenz Uhlmann Martina Bentner Andreas Schneeweiss Andreas Mueller Joachim Szecsenyi Stefanie Joos The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial Cancer Medicine breast cancer chemotherapy complementary therapies gynecologic cancer health services research nursing intervention |
| title | The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial |
| title_full | The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial |
| title_fullStr | The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial |
| title_full_unstemmed | The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial |
| title_short | The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial |
| title_sort | effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy results from a randomized controlled trial |
| topic | breast cancer chemotherapy complementary therapies gynecologic cancer health services research nursing intervention |
| url | https://doi.org/10.1002/cam4.2196 |
| work_keys_str_mv | AT nadjaklafke theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT corneliamahler theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT corneliavonhagens theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT lorenzuhlmann theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT martinabentner theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT andreasschneeweiss theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT andreasmueller theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT joachimszecsenyi theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT stefaniejoos theeffectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT nadjaklafke effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT corneliamahler effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT corneliavonhagens effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT lorenzuhlmann effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT martinabentner effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT andreasschneeweiss effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT andreasmueller effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT joachimszecsenyi effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial AT stefaniejoos effectsofanintegratedsupportivecareinterventiononqualityoflifeoutcomesinoutpatientswithbreastandgynecologiccancerundergoingchemotherapyresultsfromarandomizedcontrolledtrial |